Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GCC19CART |
Synonyms | |
Therapy Description |
GCC19CART is a chimeric antigen receptor (CAR) T-cell therapy comprising T-lymphocytes that target guanylate cyclase-C (GUY2C) and CD19, potentially resulting in antitumor activity (Cancer Res (2023) 83 (7_Supplement): 1130). |